文献速递临床微生物质量管理与危急值

评论:自动化血培养系统能否既创新又改进?

Commentary: Can Automated Blood Culture Systems Be Both New and Improved?
PubMed 文献 · J Clin Microbiol · 2022-04-04

本文评述Chavez等在《临床微生物学杂志》发表的研究,该研究基于既往工作考察引入一种新型自动化连续监测血培养系统后的临床影响。新系统宣称可提高微生物检出率并缩短阳性报警时间,但作者发现改变长期接受的性能特征带来意外后果:新系统实施确实改变了金黄色葡萄球菌菌血症患者的管理,但对患者结局无总体影响。

要点

  • 自动化连续监测血培养系统核心技术自20世纪90年代引入以来基本未变。
  • 新系统提高微生物回收率并缩短阳性检出时间,但改变管理未改善患者结局。
  • 血培养系统性能特征的稳定性支撑了质控基准、下游诊断和临床指南。

核心结论

  • 新型自动化血培养系统的引入改变了金黄色葡萄球菌菌血症患者的管理,但对患者结局无总体影响。

研究设计与样本

  • 本文为评论文章,评述Chavez等基于既往研究考察引入新型血培养系统后临床影响的研究。

主要发现

  • 新系统宣称增强微生物回收并更快速检出阳性血培养。
  • 实施新系统确实改变了金黄色葡萄球菌菌血症患者的管理。
  • 改变管理对患者结局无总体影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Automated continuous monitoring blood culture (CMBC) systems are a cornerstone of the clinical microbiology laboratory. Despite the critical role of these systems in diagnosing life-threatening bloodstream infections, their core technologies and performance characteristics have remained largely unchanged since their introduction in the 1990s. This stability and uniformity have enabled the development of quality benchmarks, such as percent positivity and contamination rate; downstream diagnostics, such as direct identification and susceptibility testing of microorganisms in positive cultures; and clinical guidelines based on time to positivity or duration of bacteriemia. In this issue of the Journal of Clinical Microbiology, Chavez et al. (J Clin Microbiol 60:e02261-21. 2021, https://doi.org/10.1128/JCM.02261-21) built on a prior study to examine clinical impacts following the introduction of a new blood culture system which boasts enhanced organism recovery and more rapid time to detection of positive blood cultures. While one might assume that these "improvements" would result in clinical benefits, the authors uncovered some unexpected consequences associated with altering long-accepted performance characteristics. Their central finding was that implementation of the new CMBC system did result in alterations to the management of patients with S. aureus bacteremia; however, this did not have any overall consequences for patient outcomes.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Buchan BW. Commentary: Can Automated Blood Culture Systems Be Both New and Improved? J Clin Microbiol. 2022. PMID: 35369711. doi:10.1128/jcm.00192-22

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。